The autoimmune/inflammatory syndrome induced by adjuvants (ASIA) was defined by Shoenfeld and Agmon-Levin as a syndrome in which exposure to an adjuvant leads to the development of a disease characterized by a hyperactive immune response. The ASIA Registry gives us a channel through which to highlight the importance of the syndrome to the scientific community. The ASIA Registry was built to provide clues about the clinical picture of ASIA across the world and to better define the disease and its causes. The registry describes the disease itself and allows us to define the demographic features of patients who develop the syndrome, including sex, age at presentation, and smoking history. There are several intrinsic limitations to data gathered through spontaneous reporting systems. This registry will enable us to define the disease criteria and discover any association of clinical manifestations, laboratory features, and pathology findings.
- Autoimmune disease
- Autoimmune/inflammatory syndrome induced by adjuvants (ASIA) registry
- Autoimmunity phenomenon